Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Vladimir Putin
United States of America
North Atlantic Treaty Organization
COVID-19
Russia-Ukraine crisis
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / World News / 'Benefits outweigh risks'; UK clears Pfizer vaccine for ages 12-15
World

'Benefits outweigh risks'; UK clears Pfizer vaccine for ages 12-15

'Benefits outweigh risks'; UK clears Pfizer vaccine for ages 12-15
Written by Siddhant Pandey
Jun 04, 2021, 05:49 pm 2 min read
'Benefits outweigh risks'; UK clears Pfizer vaccine for ages 12-15
The Pfizer-BioNTech COVID-19 vaccine was already cleared for ages 16 and over in the UK.

The United Kingdom on Friday decided to approve the COVID-19 vaccine developed by Pfizer-BioNTech for use among those aged 12-15 years. UK's Medicines and Healthcare products Regulatory Agency (MHRA) said that the decision was taken after a "rigorous review," adding that the benefits of the vaccine outweigh its risks. The move follows similar assessments in the European Union and the United States.

Announcement
UK's vaccination committee to decide if children should be vaccinated

The MHRA on Friday announced that the Pfizer vaccine has been authorized for use among those aged 12-15 years after "a rigorous review of the safety, quality, and effectiveness of the vaccine in this age group." The Joint Committee on Vaccination and Immunisation (JCVI) will decide whether children in the age group should get the vaccine as part of the deployment program.

Quote
'Benefits of this vaccine outweigh any risk'

MHRA Chief Executive Dr. June Raine said in a statement, "The Pfizer/BioNTech COVID-19 vaccine is safe and effective in this age group and that the benefits of this vaccine outweigh any risk." "We have in place a comprehensive safety surveillance strategy for monitoring the safety of all UK-approved COVID-19 vaccines and this surveillance will include the 12- to 15-year age group," she added.

Context
18+, priority groups aged 16-18 receiving Pfizer shots

Currently, there is no routine vaccination against COVID-19 among those under the age of 18 in the United Kingdom. The vaccine was already approved for use among people who are above the age of 16 years. Those aged 16-18 years are only allowed vaccination if they fall in a priority group, or live in the same house as someone extremely vulnerable.

Information
'No new side effects; safety data comparable to young adults'

The MHRA said, "No new side effects were identified and the safety data in children was comparable with that seen in young adults." The majority of adverse events were mild to moderate and were related to reactogenicity (sore arm, tiredness, etc.), the regulator added.

Other countries
US, Canada started vaccinating children aged 12-15 this month

Last month, the European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) had approved the vaccine for the age group. Both the US and Canada started vaccinating children in the age group earlier this month. Members of the EU are slated to start vaccinations in the age group this month. Germany has said the process will start from June 7.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Siddhant Pandey
Siddhant Pandey
Twitter
Siddhant Pandey covers national and health news at NewsBytes. He has over five years of experience working as a multimedia journalist covering hard news in New Delhi. He was previously employed with The Indian Express and News World India and has juggled roles as a correspondent, copy editor, and video producer. He holds a Bachelor’s degree in Biotechnology from the Jaypee Institute of Information Technology, Noida.
Latest
Pfizer
Vaccine
United Kingdom
Coronavirus
Related
Latest
2022 TVS iQube e-scooter launched in India at Rs. 98,654
2022 TVS iQube e-scooter launched in India at Rs. 98,654 Auto
Rivaling Amazon, Walmart-backed PhonePe to buy two wealth management firms
Rivaling Amazon, Walmart-backed PhonePe to buy two wealth management firms Business
Succession law: Centre supports provision prioritizing husband's kin
Succession law: Centre supports provision prioritizing husband's kin India
Delhi Lieutenant Governor Anil Baijal resigns citing 'personal reasons'
Delhi Lieutenant Governor Anil Baijal resigns citing 'personal reasons' Politics
'Tezaab': Madhuri Dixit, Anil Kapoor's classic gearing up for remake
'Tezaab': Madhuri Dixit, Anil Kapoor's classic gearing up for remake Entertainment
Pfizer
New Omicron sub-variants can trigger new COVID-19 wave: Study
New Omicron sub-variants can trigger new COVID-19 wave: Study World
'Cautious optimism' after initial Omicron studies; here's what we know
'Cautious optimism' after initial Omicron studies; here's what we know Technology
COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective
COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective Technology
COVID-19: India reports 10K+ infections; 301 more deaths
COVID-19: India reports 10K+ infections; 301 more deaths India
India may approve anti-COVID-19 drug molnupiravir soon: Report
India may approve anti-COVID-19 drug molnupiravir soon: Report India
More News
Vaccine
COVID-19: India logs 2,487 fresh cases, 13 more fatalities
COVID-19: India logs 2,487 fresh cases, 13 more fatalities India
COVID-19: India logs 2,858 fresh cases, 11 more fatalities
COVID-19: India logs 2,858 fresh cases, 11 more fatalities India
India: Phase-2 trials of world's first one-shot pneumococcal vaccine soon
India: Phase-2 trials of world's first one-shot pneumococcal vaccine soon India
India inching closer to launching its first dengue vaccine
India inching closer to launching its first dengue vaccine India
National Vaccination Day 2022: Know theme, history, significance
National Vaccination Day 2022: Know theme, history, significance Lifestyle
More News
United Kingdom
UK confirms monkeypox case: Know causes, symptoms, and treatment
UK confirms monkeypox case: Know causes, symptoms, and treatment World
UK's new visa needs no job offer: Everything to know
UK's new visa needs no job offer: Everything to know World
Modi-Johnson meet: India, UK agree to boost defense, trade ties
Modi-Johnson meet: India, UK agree to boost defense, trade ties India
Queen Elizabeth turns 96. Some facts and a throwback picture
Queen Elizabeth turns 96. Some facts and a throwback picture Lifestyle
National Tea Day: Fes-TEA-val of Britain's beloved hot beverage
National Tea Day: Fes-TEA-val of Britain's beloved hot beverage Lifestyle
More News
Coronavirus
COVID-19: India logs 3,303 new cases; 39 more deaths
COVID-19: India logs 3,303 new cases; 39 more deaths India
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man India
COVID-19 vaccine precautionary dose available for 18+ from April 10
COVID-19 vaccine precautionary dose available for 18+ from April 10 India
COVID-19 survivors at risk of developing serious blood clots: Study
COVID-19 survivors at risk of developing serious blood clots: Study Technology
COVID-19: India reports 1,660 new cases, 4,100 more deaths
COVID-19: India reports 1,660 new cases, 4,100 more deaths India
More News
Related
Pfizer, BioNTech begin clinical trial for Omicron-specific vaccine
Pfizer, BioNTech begin clinical trial for Omicron-specific vaccine World
Pfizer-BioNTech vaccine 'safe' for kids aged 5-11; generates 'robust immunity'
Pfizer-BioNTech vaccine 'safe' for kids aged 5-11; generates 'robust immunity' World
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA World
Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week
Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week World
Next News Article
Next News Article

Love World news?

Subscribe to stay updated.

World Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022